Serum levels of brain-derived neurotrophic factor in Sydenham's chorea

  • Antônio Lúcio Teixeira
  • , Thales Lage Bretas
  • , Arthur Kummer
  • , Lívia Cunha Melo
  • , Amanda Baraldi
  • , Estefânia Harsányi
  • , Francisco Cardoso
  • , Elizabeth Ribeiro Da Silva Camargos

Producción científica: Articlerevisión exhaustiva

5 Citas (Scopus)

Resumen

Sydenham's chorea (SC) is the neurologic manifestation of rheumatic fever. In addition to involuntary movements, SC patients show behavioral changes, such as hyperactivity, obsessions, and compulsions. Brain-derived neurotrophic factor (BDNF) is related to neuronal development and differentiation. Since BDNF serum levels are altered in a series of neuropsychiatric disorders, such as schizophrenia and Huntington's disease, we investigated the serum levels of BDNF in SC patients. Eighteen patients with acute SC, 4 with persistent SC and 27 control subjects were included in this study. BDNF was determined by ELISA. There was no significant difference between BDNF serum levels of control and acute SC groups (P = 0.12). Persistent SC patients presented decreased BDNF levels when compared to both control and acute SC groups (P<0.001). Our results suggest that the persistence of symptoms in SC may be related to structural changes in the central nervous system as expressed by altered BDNF levels.

Idioma originalEnglish (US)
Páginas (desde-hasta)399-401
Número de páginas3
PublicaciónNeurological Sciences
Volumen31
N.º3
DOI
EstadoPublished - jun 2010
Publicado de forma externa

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Huella

Profundice en los temas de investigación de 'Serum levels of brain-derived neurotrophic factor in Sydenham's chorea'. En conjunto forman una huella única.

Citar esto